Vertex Pharmaceuticals
VRTX
VRTX
430 hedge funds and large institutions have $26.2B invested in Vertex Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 161 increasing their positions, 140 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more funds holding
Funds holding: 411 → 430 (+19)
32% less call options, than puts
Call options by funds: $313M | Put options by funds: $459M
Holders
430
Holding in Top 10
8
Calls
$313M
Puts
$459M
Top Buyers
| 1 | +$382M | |
| 2 | +$272M | |
| 3 | +$120M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$112M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$112M |
Top Sellers
| 1 | -$288M | |
| 2 | -$173M | |
| 3 | -$159M | |
| 4 |
Goldman Sachs
New York
|
-$88.2M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$84.2M |